Cardiac Resynchronization Therapy

Moderator:

There is no moderator for this particular article.

Discussants:

There are no discussants for this particular article.
  • Summary:

    Dr. Jonathan Steinberg from Columbia University moderated the topic "Cardiac Resynchronization Therapy" with Drs. Andrew Epstein from the University of Pennsylvania and Angelo Auricchio from the Foundation Cardiocentro participating.

    The discussion focused primarily on:
    (1) the benefits, risks, and limitations of cardiac resynchronization therapy (CRT);
    (2) the challenges of CRT compared with implantable cardioverter-defibrillator/pacemaker therapy;
    (3) identification of the best candidates for CRT; and
    (4) the incorporation of medical and device management.
    (Med Roundtable Cardiovasc Ed. 2011;2(4):256-262) ©2011 FoxP2 Media, LLC
  • Compounds:
    No compounds discussed.
    Trials:

    ACT, AMICA, CARE-HF, COMPANION, MADIT-CRT, PABA CHF, RAFT, REPLACE, REVERSE

Please register or login to see this content.

Please register or login to see this content.
Please register or login to see this content.
Please subscribe to use our print features or to download PDF files.